tailieuchung - Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Đang chuẩn bị liên kết để tải về tài liệu:
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Trúc Ly 58 9 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Based on improved clinical outcomes in randomized controlled clinical trials (RCTs) the FDA and EMA have approved bevacizumab with interferon, sunitinib, and pazopanib in the first-line treatment of low to intermediate risk metastatic clear cell renal cell carcinoma (mRCC). However, there is little comparative data to help in choosing the most effective drug among these agents. |

Đang chuẩn bị liên kết để tải về tài liệu:
Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: A population-based cohort study in Ontario, Canada

The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study

A comparative effectiveness trial of postoperative management for lumbar spine surgery: Changing behavior through physical therapy (CBPT) study protocol

Design characteristics of the CORRONA CERTAIN study: A comparative effectiveness study of biologic agents for rheumatoid arthritis patients

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC)

Comparative effectiveness of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study

Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): Study protocol of a nonrandomized comparative effectiveness study

Báo cáo y học: "Comparative effectiveness of manipulation, mobilisation and the Activator instrument in treatment of non-specific neck pain: a systematic review"

Báo cáo y học: "Bending the cost curve in the United States: the role of comparative effectiveness research"

Improving Medical Decisions Through Comparative Effectiveness Research: Cancer as a Case Study

Đang chuẩn bị liên kết để tải về tài liệu: Comparative effectiveness of approved first-line anti-angiogenic and molecularly targeted therapeutic agents in the treatment of good and intermediate risk metastatic clear cell renal cell carcinoma